Peck C C, Beal S L, Sheiner L B, Nichols A I
J Pharmacokinet Biopharm. 1984 Oct;12(5):545-58. doi: 10.1007/BF01060132.
It is often difficult to specify weights for weighted least squares nonlinear regression analysis of pharmacokinetic data. Improper choice of weights may lead to inaccurate and/or imprecise estimates of pharmacokinetic parameters. Extended least squares nonlinear regression provides a possible solution to this problem by allowing the incorporation of a general parametric variance model. Weighted least squares and extended least squares analyses of data from a simulated pharmacokinetic experiment were compared. Weighted least squares analysis of the simulated data, using commonly used weighting schemes, yielded estimates of pharmacokinetic parameters that were significantly biased, whereas extended least squares estimates were unbiased. Extended least squares estimates were often significantly more precise than were weighted least squares estimates. It is suggested that extended least squares regression should be further investigated for individual pharmacokinetic data analysis.
在药代动力学数据的加权最小二乘非线性回归分析中,通常很难确定权重。权重选择不当可能导致药代动力学参数的估计不准确和/或不精确。扩展最小二乘非线性回归通过纳入一般参数方差模型,为这个问题提供了一种可能的解决方案。对来自模拟药代动力学实验的数据进行了加权最小二乘和扩展最小二乘分析比较。使用常用加权方案对模拟数据进行加权最小二乘分析,得到的药代动力学参数估计值存在显著偏差,而扩展最小二乘估计值无偏差。扩展最小二乘估计值通常比加权最小二乘估计值精确得多。建议对扩展最小二乘回归在个体药代动力学数据分析中进行进一步研究。